621 related articles for article (PubMed ID: 21248066)
1. Convalescent plasma treatment reduced mortality in patients with severe pandemic influenza A (H1N1) 2009 virus infection.
Hung IF; To KK; Lee CK; Lee KL; Chan K; Yan WW; Liu R; Watt CL; Chan WM; Lai KY; Koo CK; Buckley T; Chow FL; Wong KK; Chan HS; Ching CK; Tang BS; Lau CC; Li IW; Liu SH; Chan KH; Lin CK; Yuen KY
Clin Infect Dis; 2011 Feb; 52(4):447-56. PubMed ID: 21248066
[TBL] [Abstract][Full Text] [Related]
2. Hyperimmune IV immunoglobulin treatment: a multicenter double-blind randomized controlled trial for patients with severe 2009 influenza A(H1N1) infection.
Hung IFN; To KKW; Lee CK; Lee KL; Yan WW; Chan K; Chan WM; Ngai CW; Law KI; Chow FL; Liu R; Lai KY; Lau CCY; Liu SH; Chan KH; Lin CK; Yuen KY
Chest; 2013 Aug; 144(2):464-473. PubMed ID: 23450336
[TBL] [Abstract][Full Text] [Related]
3. Delayed clearance of viral load and marked cytokine activation in severe cases of pandemic H1N1 2009 influenza virus infection.
To KK; Hung IF; Li IW; Lee KL; Koo CK; Yan WW; Liu R; Ho KY; Chu KH; Watt CL; Luk WK; Lai KY; Chow FL; Mok T; Buckley T; Chan JF; Wong SS; Zheng B; Chen H; Lau CC; Tse H; Cheng VC; Chan KH; Yuen KY
Clin Infect Dis; 2010 Mar; 50(6):850-9. PubMed ID: 20136415
[TBL] [Abstract][Full Text] [Related]
4. Low titers of serum antibodies inhibiting hemagglutination predict fatal fulminant influenza A(H1N1) 2009 infection.
Guihot A; Luyt CE; Parrot A; Rousset D; Cavaillon JM; Boutolleau D; Fitting C; Pajanirassa P; Mallet A; Fartoukh M; Agut H; Musset L; Zoorob R; Kirilovksy A; Combadière B; van der Werf S; Autran B; Carcelain G;
Am J Respir Crit Care Med; 2014 May; 189(10):1240-9. PubMed ID: 24646009
[TBL] [Abstract][Full Text] [Related]
5. Plasma cytokine levels and cytokine gene polymorphisms in Mexican patients during the influenza pandemic A(H1N1)pdm09.
Martinez-Ocaña J; Olivo-Diaz A; Salazar-Dominguez T; Reyes-Gordillo J; Tapia-Aquino C; Martínez-Hernández F; Manjarrez ME; Antonio-Martinez M; Contreras-Molina A; Figueroa-Moreno R; Valdez-Vazquez R; Kawa-Karasik S; Rodríguez-Zulueta P; Flisser A; Maravilla P; Romero-Valdovinos M
J Clin Virol; 2013 Sep; 58(1):108-13. PubMed ID: 23809475
[TBL] [Abstract][Full Text] [Related]
6. Excess mortality is associated with influenza A (H1N1) in patients with severe acute respiratory illness.
Lobo SM; Watanabe ASA; Salomão MLM; Queiroz F; Gandolfi JV; de Oliveira NE; Covello LHS; Sacillotto GH; de Godoy LG; Simões ES; Frini ICM; Da Silva Teixeira RER; Furlan NP; Dutra KR; Nogueira ML
J Clin Virol; 2019 Jul; 116():62-68. PubMed ID: 31103803
[TBL] [Abstract][Full Text] [Related]
7. Effect of clinical and virological parameters on the level of neutralizing antibody against pandemic influenza A virus H1N1 2009.
Hung IF; To KK; Lee CK; Lin CK; Chan JF; Tse H; Cheng VC; Chen H; Ho PL; Tse CW; Ng TK; Que TL; Chan KH; Yuen KY
Clin Infect Dis; 2010 Aug; 51(3):274-9. PubMed ID: 20575664
[TBL] [Abstract][Full Text] [Related]
8. Viral load in patients infected with pandemic H1N1 2009 influenza A virus.
To KK; Chan KH; Li IW; Tsang TY; Tse H; Chan JF; Hung IF; Lai ST; Leung CW; Kwan YW; Lau YL; Ng TK; Cheng VC; Peiris JS; Yuen KY
J Med Virol; 2010 Jan; 82(1):1-7. PubMed ID: 19950247
[TBL] [Abstract][Full Text] [Related]
9. Comparison of neutralizing antibody and cell-mediated immune responses to pandemic H1N1 2009 influenza virus before and after H1N1 2009 influenza vaccination of elderly subjects and healthcare workers.
Hsu JP; Phoon MC; Koh GC; Chen MI; Lee VJ; Wu Y; Xie ML; Cheong A; Leo YS; Chow VT
Int J Infect Dis; 2012 Aug; 16(8):e621-7. PubMed ID: 22704721
[TBL] [Abstract][Full Text] [Related]
10. Cytokine responses in patients with mild or severe influenza A(H1N1)pdm09.
Bradley-Stewart A; Jolly L; Adamson W; Gunson R; Frew-Gillespie C; Templeton K; Aitken C; Carman W; Cameron S; McSharry C
J Clin Virol; 2013 Sep; 58(1):100-7. PubMed ID: 23790455
[TBL] [Abstract][Full Text] [Related]
11. Mucosal antibody responses are directed by viral burden in children with acute influenza infection.
He Y; Abid A; Fisher R; Eller N; Mikolajczyk M; Welliver RC; Bonner AB; Scott DE; Reed JL
Influenza Other Respir Viruses; 2013 Jan; 7(1):46-54. PubMed ID: 22405508
[TBL] [Abstract][Full Text] [Related]
12. Meta-analysis: convalescent blood products for Spanish influenza pneumonia: a future H5N1 treatment?
Luke TC; Kilbane EM; Jackson JL; Hoffman SL
Ann Intern Med; 2006 Oct; 145(8):599-609. PubMed ID: 16940336
[TBL] [Abstract][Full Text] [Related]
13. Association between Hemagglutinin Stem-Reactive Antibodies and Influenza A/H1N1 Virus Infection during the 2009 Pandemic.
Hoa LNM; Mai LQ; Bryant JE; Thai PQ; Hang NLK; Yen NTT; Duong TN; Thoang DD; Horby P; Werheim HFL; Fox A
J Virol; 2016 Jul; 90(14):6549-6556. PubMed ID: 27170747
[TBL] [Abstract][Full Text] [Related]
14. Prospective Observational Study on the Association Between Serum Mannose-Binding Lectin Levels and Severe Outcome in Critically Ill Patients with Pandemic Influenza Type A (H1N1) Infection.
Zogheib E; Nyga R; Cornu M; Sendid B; Monconduit J; Jounieaux V; Maizel J; Segard C; Chouaki T; Dupont H
Lung; 2018 Feb; 196(1):65-72. PubMed ID: 29273833
[TBL] [Abstract][Full Text] [Related]
15. [Experience in treating severe viral respiratory infection caused by influenza A (H1N1)].
Evdokimov AA; Malyshev NA; Protsenko DN; Belevskiĭ AS; Iaroshetskiĭ AI; Murav'ev OB; Boĭtsov PV; Gel'fand BR
Anesteziol Reanimatol; 2010; (3):22-5. PubMed ID: 20734842
[TBL] [Abstract][Full Text] [Related]
16. Recipients of vaccine against the 1976 "swine flu" have enhanced neutralization responses to the 2009 novel H1N1 influenza virus.
McCullers JA; Van De Velde LA; Allison KJ; Branum KC; Webby RJ; Flynn PM
Clin Infect Dis; 2010 Jun; 50(11):1487-92. PubMed ID: 20415539
[TBL] [Abstract][Full Text] [Related]
17. Characteristics of patients with hospital-acquired influenza A (H1N1)pdm09 virus admitted to the intensive care unit.
Álvarez-Lerma F; Marín-Corral J; Vilà C; Masclans JR; Loeches IM; Barbadillo S; González de Molina FJ; Rodríguez A;
J Hosp Infect; 2017 Feb; 95(2):200-206. PubMed ID: 28153560
[TBL] [Abstract][Full Text] [Related]
18. Clinical aspects and cytokine response in severe H1N1 influenza A virus infection.
Hagau N; Slavcovici A; Gonganau DN; Oltean S; Dirzu DS; Brezoszki ES; Maxim M; Ciuce C; Mlesnite M; Gavrus RL; Laslo C; Hagau R; Petrescu M; Studnicska DM
Crit Care; 2010; 14(6):R203. PubMed ID: 21062445
[TBL] [Abstract][Full Text] [Related]
19. IgM levels in plasma predict outcome in severe pandemic influenza.
Justel M; Socias L; Almansa R; Ramírez P; Gallegos MC; Fernandez V; Gordon M; Andaluz-Ojeda D; Nogales L; Rojo S; Vallés J; Estella A; Loza A; León C; Lopez-Mestanza C; Blanco J; Berezo JÁ; Rosich S; Cillòniz C; Torres A; de Lejarazu RO; Martin-Loeches I; Bermejo-Martin JF
J Clin Virol; 2013 Nov; 58(3):564-7. PubMed ID: 24076102
[TBL] [Abstract][Full Text] [Related]
20. Correlates of severe disease in patients with 2009 pandemic influenza (H1N1) virus infection.
Zarychanski R; Stuart TL; Kumar A; Doucette S; Elliott L; Kettner J; Plummer F
CMAJ; 2010 Feb; 182(3):257-64. PubMed ID: 20093297
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
